Dividend Paying Stocks With Stability: AbbVie’s (ABBV) Consistent Record

Core Viewpoint - AbbVie Inc. is recognized as one of the best dividend-paying stocks, with a strong track record of consistent dividend growth and a solid pipeline of treatments [1][5]. Group 1: Dividend Performance - AbbVie has a current dividend yield of 2.9%, significantly higher than the broader market's 1.2% [2]. - The company has raised its dividend by an average annual rate of 7% over the past five years, with the annual payout reaching approximately $6.56 per share, up from $5.20 in 2021 and $3.59 in 2018 [3]. - AbbVie's payout ratio is less than 50%, providing flexibility for future dividend increases [3]. Group 2: Product Pipeline and R&D Investment - AbbVie has faced patent expirations on key products like Humira but has developed a robust pipeline of around 90 treatments [4]. - The company invested nearly $11 billion in research and development in 2024, focusing on treatments in mid to late stages of progress [4]. Group 3: Dividend History - AbbVie has consistently grown its dividends for 53 consecutive years, establishing itself as a reliable dividend stock [5].